Lesley L Young - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Current Opinion in Molecular Therapeutics|March 1, 2005

Modulation of the notch pathway for immunotherapyEmmanuel Briend, Lesley L Young, Grahame J McKenzie, et al.

Seminars in Cell & Developmental Biology|March 26, 2003

Notch signalling in the regulation of peripheral T-cell functionGrahame J Mckenzie, Lesley L Young, Emmanuel Briend, et al.

The Journal of Clinical Investigation|December 9, 2003

Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanismKenneth K Wong, Matthew J Carpenter, Lesley L Young, et al.

Oncoimmunology|April 14, 2017

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Current Opinion in Molecular Therapeutics|March 1, 2005

Modulation of the notch pathway for immunotherapyEmmanuel Briend, Lesley L Young, Grahame J McKenzie, et al.

Seminars in Cell & Developmental Biology|March 26, 2003

Notch signalling in the regulation of peripheral T-cell functionGrahame J Mckenzie, Lesley L Young, Emmanuel Briend, et al.

The Journal of Clinical Investigation|December 9, 2003

Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanismKenneth K Wong, Matthew J Carpenter, Lesley L Young, et al.

Oncoimmunology|April 14, 2017

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potentialNatalie J Tigue, Lisa Bamber, John Andrews, et al.

Pageof 1